U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Hereditary site-specific ovarian cancer syndrome

MedGen UID:
1650574
Concept ID:
C4749652
Disease or Syndrome
Synonym: hereditary site-specific ovarian cancer syndrome
Modes of inheritance:
Autosomal dominant inheritance
MedGen UID:
141047
Concept ID:
C0443147
Intellectual Product
Source: Orphanet
A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele.
 
Monarch Initiative: MONDO:0016249
Orphanet: ORPHA213524

Definition

Hereditary site-specific ovarian cancer syndrome refers to ovarian cancer caused by germline mutations in various genes, usually associated with additional cancer risks. The most common are breast and ovarian cancer syndrome (HBOC) due to mutations in <i>BRCA1</i> and <i>BRCA2</i> genes and hereditary nonpolyposis colorectal cancer (HNPCC) due to mutations in DNA mismatch-repair genes. Mutations in <i>STK11</i> gene, causing Peutz-Jeghers syndrome, are also associated with a risk of ovarian cancer (typically sex cord stromal tumors). Mutations in other genes, including <i>RAD51C</i>, <i>RAD51D</i>, <i>PALB2</i>, confer an elevated ovarian cancer risk in a minority of patients. [from ORDO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • Hereditary site-specific ovarian cancer syndrome

Professional guidelines

PubMed

Foretova L, Petrakova K, Palacova M, Kalabova R, Svoboda M, Navratilova M, Schneiderova M, Bolcak K, Krejci E, Drazan L, Mikova M, Hazova J, Vasickova P, Machackova E
Klin Onkol 2010;23(6):388-400. PMID: 21348412

Recent clinical studies

Etiology

Foretova L, Petrakova K, Palacova M, Kalabova R, Svoboda M, Navratilova M, Schneiderova M, Bolcak K, Krejci E, Drazan L, Mikova M, Hazova J, Vasickova P, Machackova E
Klin Onkol 2010;23(6):388-400. PMID: 21348412
Russo A, Calò V, Bruno L, Rizzo S, Bazan V, Di Fede G
Crit Rev Oncol Hematol 2009 Jan;69(1):28-44. Epub 2008 Jul 24 doi: 10.1016/j.critrevonc.2008.06.003. PMID: 18656380
Prat J, Ribé A, Gallardo A
Hum Pathol 2005 Aug;36(8):861-70. doi: 10.1016/j.humpath.2005.06.006. PMID: 16112002
Lynch HT, Lynch J, Conway T, Watson P, Feunteun J, Lenoir G, Narod S, Fitzgibbons R Jr
World J Surg 1994 Jan-Feb;18(1):21-31. doi: 10.1007/BF00348188. PMID: 8197773
Gallion HH, Smith SA
Semin Surg Oncol 1994 Jul-Aug;10(4):249-54. doi: 10.1002/ssu.2980100404. PMID: 8091066

Diagnosis

Foretova L, Petrakova K, Palacova M, Kalabova R, Svoboda M, Navratilova M, Schneiderova M, Bolcak K, Krejci E, Drazan L, Mikova M, Hazova J, Vasickova P, Machackova E
Klin Onkol 2010;23(6):388-400. PMID: 21348412
Russo A, Calò V, Bruno L, Rizzo S, Bazan V, Di Fede G
Crit Rev Oncol Hematol 2009 Jan;69(1):28-44. Epub 2008 Jul 24 doi: 10.1016/j.critrevonc.2008.06.003. PMID: 18656380
Prat J, Ribé A, Gallardo A
Hum Pathol 2005 Aug;36(8):861-70. doi: 10.1016/j.humpath.2005.06.006. PMID: 16112002
Lynch HT, Deters CA, Lynch JF, Brand RE
Fam Cancer 2004;3(3-4):233-40. doi: 10.1007/s10689-004-9549-8. PMID: 15516847
Bewtra C, Watson P, Conway T, Read-Hippee C, Lynch HT
Int J Gynecol Pathol 1992 Jul;11(3):180-7. doi: 10.1097/00004347-199207000-00003. PMID: 1399227

Prognosis

Russo A, Calò V, Bruno L, Rizzo S, Bazan V, Di Fede G
Crit Rev Oncol Hematol 2009 Jan;69(1):28-44. Epub 2008 Jul 24 doi: 10.1016/j.critrevonc.2008.06.003. PMID: 18656380
Lynch HT, Deters CA, Lynch JF, Brand RE
Fam Cancer 2004;3(3-4):233-40. doi: 10.1007/s10689-004-9549-8. PMID: 15516847
Sarantaus L, Auranen A, Nevanlinna H
Int J Oncol 2001 Apr;18(4):831-5. doi: 10.3892/ijo.18.4.831. PMID: 11251181
Gallion HH, Smith SA
Semin Surg Oncol 1994 Jul-Aug;10(4):249-54. doi: 10.1002/ssu.2980100404. PMID: 8091066
Lynch HT, Watson P, Bewtra C, Conway TA, Hippee CR, Kaur P, Lynch JF, Ponder BA
Cancer 1991 Mar 1;67(5):1460-6. doi: 10.1002/1097-0142(19910301)67:5<1460::aid-cncr2820670534>3.0.co;2-s. PMID: 1991314

Clinical prediction guides

Goshen R, Chu W, Elit L, Pal T, Hakimi J, Ackerman I, Fyles A, Mitchell M, Narod SA
Gynecol Oncol 2000 Dec;79(3):477-81. doi: 10.1006/gyno.2000.6003. PMID: 11104623
Liede A, Tonin PN, Sun CC, Serruya C, Daly MB, Narod SA, Foulkes WD
Am J Med Genet 1998 Jan 6;75(1):55-8. doi: 10.1002/(sici)1096-8628(19980106)75:1<55::aid-ajmg12>3.0.co;2-r. PMID: 9450858
Spurr NK, Kelsell DP, Black DM, Murday VA, Turner G, Crockford GP, Solomon E, Cartwright RA, Bishop DT
Am J Hum Genet 1993 Apr;52(4):777-85. PMID: 8460643Free PMC Article
Lynch HT, Watson P, Bewtra C, Conway TA, Hippee CR, Kaur P, Lynch JF, Ponder BA
Cancer 1991 Mar 1;67(5):1460-6. doi: 10.1002/1097-0142(19910301)67:5<1460::aid-cncr2820670534>3.0.co;2-s. PMID: 1991314

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...